Worldwide outreach for a global challenge: Brucellosis Vaccine Prize presented at scientific events around the world
Since applications opened at the Brucellosis International Research Conference late last year, the Brucellosis Vaccine Prize competition has been presented at a number of key scientific events across the globe. Funded by AgResults and implemented by GALVmed, the US $30 million competition invites vaccine developers to submit their proposals for – and ultimately develop – a suitable vaccine that is efficacious, safe and viable for use against Brucella melitensis in small ruminants across the developing world.
Last month, the competition was showcased at the Veterinary Vaccinology Network’s annual conference – and GALVmed CEO Peter Jeffries presented details to a group of researchers at a Biotechnology and Biological Sciences Research Council (BBSRC) meeting on zoonotic diseases. Here, Peter outlines the purpose and nature of the competition – the first of its kind in animal health.
https://www.youtube.com/watch?v=ERu7zzTSjFU
The Brucellosis Vaccine Prize team will be present at a number of other events throughout the year, including next week’s Animal Health Investment Europe Forum, taking place in London on 22nd and 23rd February. For more information on the event schedule or the competition in general, please email [email protected].
Related posts
-
Video: GALVmed CEO Peter Jeffries encourages applicants to apply for the Brucellosis Vaccine Prize
Inviting applicants to enter the Brucellosis Vaccine Prize, Peter Jeffries outlines the benefits for commercial and academic organisations joining forces to collaborate on the US $30m competition.
-
Video: GALVmed’s CEO Peter Jeffries gives an update on the Brucellosis Vaccine PrizeNew Blog Post
Peter Jeffries summarises the Brucellosis Vaccine Prize, discussing the need for a new vaccine and the criteria for entry, as the US $30m competition enters its second phase.
-
Interview with Andrew Soldan of the Animal and Plant Health Agency’s APHA Scientific
If you have read July’s International Animal Health Journal, you will have seen Professor Javier Guitián from the Royal Veterinary College (RVC) explain that successful control of brucellosis in developed...
-
Industry Response: Brucellosis Vaccine Prize Competition
Peter Oostenbach, Associate Director for Global Public Policy Animal Health at Merck Animal Health/MSD Animal Health responds with his personal view.
